[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Depending on the response to treatment, group 1 will receive Tofacitinib at a dose of 10 mg twice daily (for 5 days) in addition to the 5-day course of Remdesivir (Administration of 200 mg of Remdesivir on the first day and then 100 mg intravenously four days later). Group 2, depending on the response to treatment, will receive Tofacitinib at a dose of 10 mg twice daily (for 5 days) along with a 10-day course of Remdesivir (Administration of 200 mg of Remdesivir on the first day and then 100 mg intravenously on the next nine days) .", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Group 3, depending on the response to treatment, receives a 5-day course of Remdesivir (Administration of 200 mg of Remdesivir on the first day and then 100 mg intravenously four days later) with placebo, which will be given twice a day for 5 days. Group 4 will also receive a 10-day Remdesivir course (Administration of 200 mg of Remdesivir on the first day and then 100 mg intravenously on the next nine days) with a placebo that will be given twice daily for 5 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]